Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikas A Gupta

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Blood|July 3, 2025
Another 1q bites the dustVikas A Gupta, Lawrence H Boise
Blood|March 3, 2022
It takes T to tango: immunotherapy in MMVikas A Gupta, Madhav V Dhodapkar
British Journal of Haematology|March 16, 2025
BCL2 inhibition for multiple myeloma and AL amyloidosisLorenzo Cani, Vikas A Gupta, Jonathan L Kaufman
JCO Oncology Practice|February 11, 2020
Approaches to Treating Multiple Myeloma, Now and Moving ForwardVikas A Gupta, Nisha S Joseph, Ajay K Nooka
Blood and Lymphatic Cancer : Targets and Therapy|March 19, 2021
BCL2 Family Inhibitors in the Biology and Treatment of Multiple MyelomaVikas A Gupta, James Ackley, Jonathan L Kaufman, et al.
Frontiers in Immunology|June 25, 2019
Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple MyelomaBenjamin G Barwick, Vikas A Gupta, Paula M Vertino, et al.
Molecular and Cellular Biology|May 19, 2005
A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cellsJeroen P Roose, Marianne Mollenauer, Vikas A Gupta, et al.
The Journal of Experimental Medicine|November 13, 2008
B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiencyVikas A Gupta, Michelle L Hermiston, Gail Cassafer, et al.
Immunity|December 17, 2005
The juxtamembrane wedge negatively regulates CD45 function in B cellsMichelle L Hermiston, Allison L Tan, Vikas A Gupta, et al.
Blood|February 3, 2017
Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myelomaVikas A Gupta, Shannon M Matulis, Jason E Conage-Pough, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Blood|July 3, 2025
Another 1q bites the dustVikas A Gupta, Lawrence H Boise
Blood|March 3, 2022
It takes T to tango: immunotherapy in MMVikas A Gupta, Madhav V Dhodapkar
British Journal of Haematology|March 16, 2025
BCL2 inhibition for multiple myeloma and AL amyloidosisLorenzo Cani, Vikas A Gupta, Jonathan L Kaufman
JCO Oncology Practice|February 11, 2020
Approaches to Treating Multiple Myeloma, Now and Moving ForwardVikas A Gupta, Nisha S Joseph, Ajay K Nooka
Blood and Lymphatic Cancer : Targets and Therapy|March 19, 2021
BCL2 Family Inhibitors in the Biology and Treatment of Multiple MyelomaVikas A Gupta, James Ackley, Jonathan L Kaufman, et al.
Frontiers in Immunology|June 25, 2019
Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple MyelomaBenjamin G Barwick, Vikas A Gupta, Paula M Vertino, et al.
Molecular and Cellular Biology|May 19, 2005
A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cellsJeroen P Roose, Marianne Mollenauer, Vikas A Gupta, et al.
The Journal of Experimental Medicine|November 13, 2008
B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiencyVikas A Gupta, Michelle L Hermiston, Gail Cassafer, et al.
Immunity|December 17, 2005
The juxtamembrane wedge negatively regulates CD45 function in B cellsMichelle L Hermiston, Allison L Tan, Vikas A Gupta, et al.
Blood|February 3, 2017
Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myelomaVikas A Gupta, Shannon M Matulis, Jason E Conage-Pough, et al.
Pageof 4